Literature DB >> 22264180

Surgical treatment of patients with vestibular schwannomas after failed previous radiosurgery.

Venelin M Gerganov1, Mario Giordano, Amir Samii, Madjid Samii.   

Abstract

OBJECT: An increasing number of patients with vestibular schwannomas (VSs) are being treated with radiosurgery. Treatment failure or secondary regrowth after radiosurgery, however, has been observed in 2%-9% of patients. In large tumors that compress the brainstem and in patients who experience rapid neurological deterioration, surgical removal is the only reasonable management option.
METHODS: The authors evaluated the relevance of previous radiosurgery for the outcome of surgery in a series of 28 patients with VS. The cohort was further subdivided into Group A (radiosurgery prior to surgery) and Group B (partial tumor removal followed by radiosurgery prior to current surgery). The functional and general outcomes in these 2 groups were compared with those in a control group (no previous treatment, matched characteristics). RESULTS There were 15 patients in Group A, 13 in Group B, and 30 in the control group. The indications for surgery were sustained tumor enlargement and progression of neurological symptoms in 12 patients, sustained tumor enlargement in 15 patients, and worsening of neurological symptoms without evidence of tumor growth in 1 patient. Total tumor removal was achieved in all patients in Groups A and B and in 96.7% of those in the control group. There were no deaths in any group. Although no significant differences in the neurological morbidity or complication rates after surgery were noted, the risk of new cranial nerve deficits and CSF leakage was highest in patients in Group B. Patients who underwent previous radiosurgical treatment (Groups A and B) tended to be at higher risk of developing postoperative hematomas in the tumor bed or cerebellum. The rate of facial nerve anatomical preservation was highest in those patients who were not treated previously (93.3%) and decreased to 86.7% in the patients in Group A and to 61.5% in those in Group B. Facial nerve function at follow-up was found to correlate to the previous treatment; excellent or good function was seen in 87% of the patients from the control group, 78% of those in Group A, and 68% of those in Group B.
CONCLUSIONS: Complete microsurgical removal of VSs after failed radiosurgery is possible with an acceptable morbidity rate. The functional outcome, however, tends to be worse than in nontreated patients. Surgery after previous partial tumor removal and radiosurgery is most challenging and related to worse outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22264180     DOI: 10.3171/2011.12.JNS111682

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Surgical management of vestibular schwannomas after failed radiation treatment.

Authors:  Yoichi Nonaka; Takanori Fukushima; Kentaro Watanabe; Allan H Friedman; Calhoun D Cunningham; Ali R Zomorodi
Journal:  Neurosurg Rev       Date:  2016-01-19       Impact factor: 3.042

2.  Subtotal petrosectomy and cerebrospinal fluid leakage in unilateral anacusis.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Mario Ciniglio Appiani; Massimo Re
Journal:  J Neurol Surg B Skull Base       Date:  2014-05-27

Review 3.  [Surgical indications and complications management in vestibular schwannoma].

Authors:  S Rosahl; D Eßer
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

Review 4.  [Update on diagnostics and microsurgical treatment of vestibular schwannoma].

Authors:  F H Ebner; M Tatagiba
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

5.  Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.

Authors:  Kerstin A Kessel; Hanna Fischer; Marco M E Vogel; Markus Oechsner; Henning Bier; Bernhard Meyer; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2016-11-01       Impact factor: 3.621

6.  Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study.

Authors:  Chloe Dumot; Stylianos Pikis; Georgios Mantziaris; Zhiyuan Xu; Rithika Kormath Anand; Ahmed M Nabeel; Darrah Sheehan; Kimball Sheehan; Wael A Reda; Sameh R Tawadros; Khaled Abdel Karim; Amr M N El-Shehaby; Reem M Emad Eldin; Selcuk Peker; Yavuz Samanci; Tehila Kaisman-Elbaz; Herwin Speckter; Wenceslao Hernández; Julio Isidor; Manjul Tripathi; Renu Madan; Brad E Zacharia; Lekhaj C Daggubati; Nuria Martínez Moreno; Roberto Martínez Álvarez; Anne-Marie Langlois; David Mathieu; Christopher P Deibert; Vivek R Sudhakar; Christopher P Cifarelli; Denisse Arteaga Icaza; Daniel T Cifarelli; Zhishuo Wei; Ajay Niranjan; Gene H Barnett; L Dade Lunsford; Greg N Bowden; Jason P Sheehan
Journal:  J Neurooncol       Date:  2022-09-27       Impact factor: 4.506

7.  Massive Cerebrospinal Fluid Leak of the Temporal Bone.

Authors:  Giannicola Iannella; Alessandra Manno; Emanuela Pasqualitto; Andrea Ciofalo; Diletta Angeletti; Benedetta Pasquariello; Giuseppe Magliulo
Journal:  Case Rep Otolaryngol       Date:  2016-08-11

8.  Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression.

Authors:  Ali Harati; Kai-Michael Scheufler; Rolf Schultheiss; Albaraa Tonkal; Kamran Harati; Paul Oni; Thomas Deitmer
Journal:  Surg Neurol Int       Date:  2017-04-05

9.  Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions.

Authors:  Jonathan H Sherman; Zachary A Smith; Jin Mo Cho; Michael Lim; Chaim B Colen; Chae-Yong Kim; Vincent Yat Wang; Gabriel Zada; Gordon Li; Isaac Yang
Journal:  Surg Neurol Int       Date:  2013-03-25

10.  Long-term facial nerve function following facial reanimation after translabyrinthine vestibular schwannoma surgery: A comparison between sural grafting and VII-XII anastomosis.

Authors:  Zhaoyan Wang; Zhihua Zhang; Qi Huang; Jun Yang; Hao Wu
Journal:  Exp Ther Med       Date:  2013-05-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.